{"id":42418,"date":"2021-10-30T11:29:12","date_gmt":"2021-10-30T15:29:12","guid":{"rendered":"https:\/\/sciencebusiness.technewslit.com\/?p=42418"},"modified":"2021-10-30T11:29:12","modified_gmt":"2021-10-30T15:29:12","slug":"infographic-record-q3-global-health-investments","status":"publish","type":"post","link":"https:\/\/technewslit.com\/sciencebusiness\/?p=42418","title":{"rendered":"Infographic – Record Q3 Global Health Investments"},"content":{"rendered":"
\"Health<\/a>
Click on image for full-size view (CB Insights)<\/figcaption><\/figure>\n

30 Oct. 2021. Venture investment volumes in health care and life science start-up companies hit record levels so far in 2021, already surpassing levels for all of 2020. Technology market research company CB Insights<\/a> highlights these investment trends in its recent report on quarterly global health care funding (registration required).<\/p>\n

The CB Insights report covers venture funding for companies in digital health, medical devices, biopharmaceuticals, digital therapeutics, health IT, mental health and wellness technologies, and telehealth worldwide. The $97.8 billion invested in companies developing these technologies so far in 2021 far exceeds the $80.5 billion invested in all of 2020, in about 90 percent of the deals recorded last year. But the 1,904 health care investment deals in just Q3 2021 is also a record, up 15 percent from the previous record of 1,668 deals in the first quarter of 2021.<\/p>\n

Venture investments in U.S. health care technology companies totaled $18.3 billion, or 60 percent of the total $30.7 billion invested in this sector in the third quarter, with U.S. companies making up 808 or 42 percent of the transactions. Asian health care technology companies raised $8.6 billion in Q3 in 730 deals, or 38 percent of the total for the quarter. CB Insights says that’s a record percentage for Asian health care venture deals, up 9 points from the third quarter of 2020.<\/p>\n

Health care start-ups in Europe raised $2.8 billion in 256 deals during the third quarter, while Canadian companies received some $400 million in 41 deals, and companies in Latin America raised about $100 million in 25 deals. All other regions received some $500 million in 44 transactions.<\/p>\n

More from Science & Enterprise:<\/p>\n